Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 3 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• Multicenter Phase I Study of HRS-6208 in Patients With Solid TumorsRecruitingNCT06727812Phase 1
• A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid TumorsNot yet recruitingNCT06704828Phase 2
• A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid TumorsRecruitingNCT06703177Phase 1/2
• A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and PrednisoneRecruitingNCT06689163Phase 1/2
• A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer PatientsRecruitingNCT06679036Phase 1/2
• A Trial of SHR-A2102 for Treatment of Advanced Gynecological MalignancyRecruitingNCT06654440Phase 2
• SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT06649292Phase 3
• A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant TumorsRecruitingNCT06643754Phase 1/2
• A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial CarcinomaRecruitingNCT06639347Phase 1/2
• A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02)RecruitingNCT06618664Phase 3
• A Study of SHR-3821 Injection in Subjects With Advanced Solid TumorsRecruitingNCT06618651Phase 1
• A Trial of SHR-7787 Injection in Patients With Advanced Solid TumorsRecruitingNCT06605222Phase 1/2
• A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06598735Phase 1
• Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer PatientsNot yet recruitingNCT06592625Phase 2
• A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT06589778Phase 1/2
• A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerRecruitingNCT06568094Phase 1/2
• A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep ApneaNot yet recruitingNCT06565871Phase 2
• A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid TumorsRecruitingNCT06555068Phase 1/2
• Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo NodularisRecruitingNCT06554509Phase 2/3
• A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic SurgeryRecruitingNCT06529432Phase 2
• A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid TumorsRecruitingNCT06520488Phase 1/2
• A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT06512051Phase 1/2
• A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy ParticipantsNot yet recruitingNCT06506175Phase 1
• A Clinical Study of SHR-9539 in Patients With Multiple MyelomaRecruitingNCT06484777Phase 1
• A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal CancerRecruitingNCT06474468Phase 1/2
• A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsRecruitingNCT06474455Phase 1/2
• A Trial of SHR-4849 in Advanced Solid TumorsRecruitingNCT06443489Phase 1
• A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma PatientsRecruitingNCT06441812Phase 2
• Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid TumorsRecruitingNCT06439589Phase 1/2
• A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 MutationsRecruitingNCT06430437Phase 3
• A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis BRecruitingNCT06425341Phase 2
• A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid TumorsRecruitingNCT06417554Phase 1/2
• SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian CancerRecruitingNCT06394492Phase 3
• A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant TumourRecruitingNCT06383871Phase 1
• Comparison of HR011408 and NovoRapid® in Subjects With DiabeticsRecruitingNCT06375031Phase 1
• A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular LymphomaNot yet recruitingNCT06368167Phase 2
• SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid TumorRecruitingNCT06350006Phase 1
• Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.Not yet recruitingNCT06346925Phase 1
• Drug-drug Interaction Study of HRS-1780 Tablets in Healthy SubjectsNot yet recruitingNCT06344936Phase 1
• A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric PatientsRecruitingNCT06344091Phase 4
• A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC PatientsNot yet recruitingNCT06335355Phase 2/3
• A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian CancerRecruitingNCT06308406Phase 1/2
• Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast CancerRecruitingNCT06222879Phase 1/2
• A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic ProceduresNot yet recruitingNCT06216444Phase 4
• A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian CancerNot yet recruitingNCT06211023Phase 2/3
• A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food EffectsNot yet recruitingNCT06175949Phase 1
• A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell LymphomaRecruitingNCT06173999Phase 1/2
• Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerRecruitingNCT06167694Phase 1/2
• A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute PyelonephritisNot yet recruitingNCT06144060Phase 2
• Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant TumorsNot yet recruitingNCT06131216Phase 1
• SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing RegimenRecruitingNCT06123494Phase 3
• SHR2554 Clinical Study of Chidamide in the Treatment of T-cell LymphomaRecruitingNCT06122389Phase 3
• A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)RecruitingNCT06108492Phase 1
• A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's LymphomaRecruitingNCT06104553Phase 1/2
• Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)Not yet recruitingNCT06099990Phase 1
• An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid TumorsRecruitingNCT06094556Phase 1
• A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid TumorsNot yet recruitingNCT06092268Phase 1/2
• A Trial of HRS-7450 in Chinese Healthy VolunteersNot yet recruitingNCT06087094Phase 1
• Study of the Food Effects of Herombopag Olamine Tablets in Healthy SubjectsNot yet recruitingNCT06062680Phase 1
• Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate CancerNot yet recruitingNCT06062355Phase 1
• Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant TumorsRecruitingNCT06059508Phase 1
• Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal FunctionNot yet recruitingNCT06039254Phase 1
• A Trial of SP2086 With Hepatic InsufficiencyNot yet recruitingNCT06035406Phase 1
• A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.RecruitingNCT06015048Phase 1/2
• Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate CancerNot yet recruitingNCT06006104Phase 1/2
• A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 DiabetesRecruitingNCT05996380Phase 1
• A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）RecruitingNCT05979051Phase 2/3
• Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)RecruitingNCT05942001Phase 1
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal WomenRecruitingNCT05930704Phase 1
• A Study of SHR-A1811 in Subjects With Gynaecologic OncologyRecruitingNCT05896020Phase 2
• An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.RecruitingNCT05884255Phase 3
• Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant TumorsRecruitingNCT05851092Phase 1
• A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.RecruitingNCT05845138Phase 1/2
• The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid TumorsRecruitingNCT05836948Phase 1
• A Study of SHR-4602 in Subjects With Advanced Malignant Solid TumorsRecruitingNCT05819684Phase 1
• Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis BRecruitingNCT05808374Phase 1
• Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic AnemiaRecruitingNCT05797623Phase 2
• A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid TumorsRecruitingNCT05794477Phase 1/2
• A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.Not yet recruitingNCT05792410Phase 1/2
• HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic CancerRecruitingNCT05751850Phase 3
• A Phase 1 Study of SHR-A2102 in Subjects With Advanced Solid Tumors.RecruitingNCT05735275Phase 1
• Phase I Study of SHR-A2102 in Patients With Advanced Solid TumorsRecruitingNCT05701709Phase 1
• Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerRecruitingNCT05671822Phase 2
• A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast CancerRecruitingNCT05628870Phase 1
• A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer SubjectsRecruitingNCT05607693Phase 1
• Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung CancerNot yet recruitingNCT05503888Phase 1/2
• A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung CancerRecruitingNCT05482568Phase 1/2
• Study of HRS-1167 as Monotherapy in Patients With Advanced Solid TumorsRecruitingNCT05473624Phase 1
• Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT05444088Phase 1/2
• A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine FibroidsRecruitingNCT05442827Phase 2/3
• Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung CancerRecruitingNCT05416775Phase 1/2
• A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBCRecruitingNCT05410730Phase 1/2
• A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing CancersEnrolling by invitationNCT05349409Phase 2
• SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal CancerRecruitingNCT05300269Phase 2
• A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORSRecruitingNCT05277168Phase 1/2
• A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of AdultsEnrolling by invitationNCT05189717Phase 1
• A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative ColitisRecruitingNCT05181137Phase 3
• A Study of SHR-A1912 for Injection in Patients With B Cell LymphomasEnrolling by invitationNCT05113069Phase 1
• A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung CancerRecruitingNCT05042375Phase 3
• The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.Enrolling by invitationNCT04691063Phase 3

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas